CompletedNCT04278586
Online Mindfulness During Buprenorphine Treatment
About this title
Read the official source — NCT04278586Behavioural studyAges 18–70United StatesAnxiety
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- SomervilleSee all locations and recruitment
Study information
Study start dateStarted: February 15, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 260
- Sponsor
- Cambridge Health Alliance
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04278586
- Official title
Show the full official title
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Somerville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cambridge Health Alliance.
Who was this study for?
Listed age limits: 18 years to 70 years.
